Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 1
2008 2
2009 5
2010 1
2011 6
2012 4
2013 4
2014 2
2015 6
2016 5
2017 3
2018 1
2019 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

42 results
Results by year
Filters applied: . Clear all
Page 1
Agomelatine for depression: expanding the horizons?
Norman TR, Olver JS. Norman TR, et al. Expert Opin Pharmacother. 2019 Apr;20(6):647-656. doi: 10.1080/14656566.2019.1574747. Epub 2019 Feb 13. Expert Opin Pharmacother. 2019. PMID: 30759026 Review.
Agomelatine is an antidepressant with unique pharmacological actions; it is both a melatonin agonist and selective serotonin antagonist. ...Depression in Parkinson's disease, cardiovascular illness and type II diabetes is reviewed with evidence of efficacy. Bipol
Agomelatine is an antidepressant with unique pharmacological actions; it is both a melatonin agonist and selective serotonin antagoni
The bipolarity of light and dark: A review on Bipolar Disorder and circadian cycles.
Abreu T, Bragança M. Abreu T, et al. J Affect Disord. 2015 Oct 1;185:219-29. doi: 10.1016/j.jad.2015.07.017. Epub 2015 Jul 26. J Affect Disord. 2015. PMID: 26241867 Review.
METHODS: It was conducted a literature search on PubMed database using the search terms "bipolar", "circadian", "melatonin", "cortisol", "body temperature", "Clock gene", "Bmal1 gene", "Per gene", "Cry gene", "GSK3β", "chronotype", "light therapy", "dark therapy", "sleep d …
METHODS: It was conducted a literature search on PubMed database using the search terms "bipolar", "circadian", "melatonin", "cortiso …
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, Egger M, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JPA, Geddes JR. Cipriani A, et al. Lancet. 2018 Apr 7;391(10128):1357-1366. doi: 10.1016/S0140-6736(17)32802-7. Epub 2018 Feb 21. Lancet. 2018. PMID: 29477251 Free PMC article. Review.
We excluded quasi-randomised trials and trials that were incomplete or included 20% or more of participants with bipolar disorder, psychotic depression, or treatment-resistant depression; or patients with a serious concomitant medical illness. ...For acceptability, only …
We excluded quasi-randomised trials and trials that were incomplete or included 20% or more of participants with bipolar disorder, ps …
Agomelatine in depression.
Smeraldi E, Delmonte D. Smeraldi E, et al. Expert Opin Drug Saf. 2013 Nov;12(6):873-80. doi: 10.1517/14740338.2013.828690. Epub 2013 Sep 16. Expert Opin Drug Saf. 2013. PMID: 24033095 Review.
AREAS COVERED: The literature about agomelatine has been comprehensively reviewed. Agomelatine's efficacy, safety and tolerability are reviewed based on the studies undertaken in patients with major depressive disorder (MDD) and bipolar disorder (BPD). …
AREAS COVERED: The literature about agomelatine has been comprehensively reviewed. Agomelatine's efficacy, safety and t …
Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depression.
De Berardis D, Fornaro M, Serroni N, Campanella D, Rapini G, Olivieri L, Srinivasan V, Iasevoli F, Tomasetti C, De Bartolomeis A, Valchera A, Perna G, Mazza M, Di Nicola M, Martinotti G, Di Giannantonio M. De Berardis D, et al. Int J Mol Sci. 2015 Jan 5;16(1):1111-30. doi: 10.3390/ijms16011111. Int J Mol Sci. 2015. PMID: 25569089 Free PMC article. Review.
Agomelatine's antidepressant actions are attributed to its sleep-promoting and chronobiotic actions mediated by MT1 and MT2 receptors present in the suprachiasmatic nucleus, as well as to its effects on the blockade of 5-HT2c receptors. ...Agomelatine appeare
Agomelatine's antidepressant actions are attributed to its sleep-promoting and chronobiotic actions mediated by MT1 and MT2 re
Agomelatine or placebo as adjunctive therapy to a mood stabiliser in bipolar I depression: randomised double-blind placebo-controlled trial.
Yatham LN, Vieta E, Goodwin GM, Bourin M, de Bodinat C, Laredo J, Calabrese J; Agomelatine Study Group. Yatham LN, et al. Br J Psychiatry. 2016 Jan;208(1):78-86. doi: 10.1192/bjp.bp.114.147587. Epub 2015 May 21. Br J Psychiatry. 2016. PMID: 25999335 Clinical Trial.
AIMS: To examine the efficacy of agomelatine v. placebo as adjuncts to lithium or valproate in bipolar depression. METHOD: Patients who were currently depressed despite taking lithium or valproate for at least 6 weeks were randomised to treatment with agomelatine
AIMS: To examine the efficacy of agomelatine v. placebo as adjuncts to lithium or valproate in bipolar depression. METHOD: Pat …
The use of agomelatine in OCD: effects on the motivational aspects and dysregulated circadian rhythms.
Perugi G, Quaranta G, Bucci N. Perugi G, et al. Expert Opin Investig Drugs. 2015 May;24(5):705-13. doi: 10.1517/13543784.2015.1021918. Epub 2015 Mar 1. Expert Opin Investig Drugs. 2015. PMID: 25727766 Review.
In particular, patients often continue to show disrupted circadian rhythms with related sleep disturbances and comorbidity with bipolar spectrum disorders. ...Indeed, the authors believe that agomelatine could be a valid alternative drug in treatment-resistant OCD p …
In particular, patients often continue to show disrupted circadian rhythms with related sleep disturbances and comorbidity with bipolar
Focus on agomelatine.
Green B. Green B. Curr Med Res Opin. 2011 Apr;27(4):745-9. doi: 10.1185/03007995.2011.554534. Epub 2011 Jan 27. Curr Med Res Opin. 2011. PMID: 21271795 Review.
FINDINGS: Agomelatine has antidepressant properties and from early on in its prescription agomelatine can improve sleep architecture and efficiency. ...Agomelatine is contraindicated in patients with impaired liver function and repeated liver function tests a …
FINDINGS: Agomelatine has antidepressant properties and from early on in its prescription agomelatine can improve sleep archit …
Agomelatine in depressive disorders: its novel mechanisms of action.
Srinivasan V, Zakaria R, Othman Z, Lauterbach EC, Acuña-Castroviejo D. Srinivasan V, et al. J Neuropsychiatry Clin Neurosci. 2012 Summer;24(3):290-308. doi: 10.1176/appi.neuropsych.11090216. J Neuropsychiatry Clin Neurosci. 2012. PMID: 23037643 Review.
Agomelatine has been shown to be effective in a number of animal models of depression. Clinical studies undertaken on patients with major depression, bipolar disorders, seasonal affective disorder, and generalized anxiety disorder have all shown that agomelatine
Agomelatine has been shown to be effective in a number of animal models of depression. Clinical studies undertaken on patients with m
Agomelatine treatment of major depressive disorder.
Dolder CR, Nelson M, Snider M. Dolder CR, et al. Ann Pharmacother. 2008 Dec;42(12):1822-31. doi: 10.1345/aph.1L296. Epub 2008 Nov 25. Ann Pharmacother. 2008. PMID: 19033480 Review.
In these 3 investigations, agomelatine produced effects on depressive symptoms similar to those of the comparator drugs. A small number of studies have demonstrated sleep benefits with the use of agomelatine in depressed patients. Positive findings also exist for th …
In these 3 investigations, agomelatine produced effects on depressive symptoms similar to those of the comparator drugs. A small numb …
42 results
Jump to page
Feedback